217 related articles for article (PubMed ID: 36515256)
1. Vespa velutina nigrithorax venom allergy: inhibition studies approach for the choice of specific immunotherapy.
Grossi V; Severino M; Massolo A; Infantino M; Laureti F; Macchia D; Meucci E; Francescato E; Pantera B; Ebbli A; Fumagalli F; Lari B; Perri A; Liotti I; Ciotta G; Terenzi G; Valeva SV; Consolati M; Folgore T; Manfredi M
Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):161-165. PubMed ID: 36515256
[No Abstract] [Full Text] [Related]
2. Anaphylaxis to Vespa velutina nigrithorax: Pattern of Sensitization for an Emerging Problem in Western Countries.
Vidal C; Armisén M; Monsalve R; González-Vidal T; Lojo S; López-Freire S; Méndez P; Rodríguez V; Romero L; Galán A; González-Quintela A
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):228-235. PubMed ID: 32043465
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV of the Vespa velutina nigrithorax venom is recognized as a relevant allergen.
Pretre G; Asturias JA; Lizaso MT; Tabar AI
Ann Allergy Asthma Immunol; 2022 Jul; 129(1):101-105. PubMed ID: 35247597
[TBL] [Abstract][Full Text] [Related]
4. Venom immunotherapy in patients with allergic reactions to insect stings.
Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with Vespula venom for Vespa velutina nigrithorax anaphylaxis: Preliminary clinical and immunological results.
Rodríguez-Vázquez V; Armisén M; Gómez-Rial J; Lamas-Vázquez B; Vidal C
Clin Exp Allergy; 2022 Feb; 52(2):345-347. PubMed ID: 34735733
[No Abstract] [Full Text] [Related]
6.
Macchia D; Cortellini G; Mauro M; Meucci E; Quercia O; Manfredi M; Massolo A; Valentini M; Severino M; Passalacqua G
World Allergy Organ J; 2018; 11(1):3. PubMed ID: 29441146
[TBL] [Abstract][Full Text] [Related]
7. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
8. [Insect venom allergies-What will change in times of global change?].
Ruëff F
Dermatologie (Heidelb); 2024 Feb; 75(2):126-133. PubMed ID: 38214725
[TBL] [Abstract][Full Text] [Related]
9. The Asian wasp Vespa velutina nigrithorax: Entomological and allergological characteristics.
Vidal C
Clin Exp Allergy; 2022 Apr; 52(4):489-498. PubMed ID: 34822191
[TBL] [Abstract][Full Text] [Related]
10. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
11. Field sting reactions in patients receiving Hymenoptera venom immunotherapy: real-life experience.
Sözener ZÇ; Kendirlinan R; Çerçi P; Ayd N Ö; Mungan D; Bavbek S; Demirel Y; Mısırl Gil Z; Sin BA
Asian Pac J Allergy Immunol; 2023 Sep; 41(3):186-192. PubMed ID: 35278056
[TBL] [Abstract][Full Text] [Related]
12. Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio.
Saulite I; Hoetzenecker W; Guenova E; Schmid-Grendelmeier P; Glatz M
Int Arch Allergy Immunol; 2017; 174(3-4):190-199. PubMed ID: 29130986
[TBL] [Abstract][Full Text] [Related]
13. Managing systemic reactions and venom immunotherapy in vespid-venom allergy: observations from a retrospective study of Portuguese patients.
Ferreira SC; Gomes M; Vieira J; Caldeira L; Silva MI; Ferreira MB; Pedro E; Cosme J
Eur Ann Allergy Clin Immunol; 2024 Jun; ():. PubMed ID: 38919151
[No Abstract] [Full Text] [Related]
14. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
[TBL] [Abstract][Full Text] [Related]
15. Venom immunotherapy for preventing allergic reactions to insect stings.
Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
[TBL] [Abstract][Full Text] [Related]
16. Basophil Activation Test in Double-Sensitized Patients With Hymenoptera Venom Allergy: Additional Benefit of Component-Resolved Diagnostics.
Schmidle P; Blank S; Altrichter S; Hoetzenecker W; Brockow K; Darsow U; Biedermann T; Eberlein B
J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2890-2899.e2. PubMed ID: 37302791
[TBL] [Abstract][Full Text] [Related]
17. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT.
Çetin GP; Yılmaz İ; Türk M; Arslan B; Bahçecioğlu SN
Turk J Med Sci; 2022 Aug; 52(4):1223-1234. PubMed ID: 36326412
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Hymenoptera venom allergy.
Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
[TBL] [Abstract][Full Text] [Related]
19. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
20. Social wasps in Spain: the who and where.
Vega JM; Ortiz-Sánchez FJ; Martínez-Arcediano A; Castro L; Alfaya T; Carballada F; Cruz S; Marqués L; Vega A; Ruiz-León B
Allergol Immunopathol (Madr); 2022; 50(2):58-64. PubMed ID: 35257546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
